• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NCM
    7.98 Up 0.23(2.97%) Jul 31, 4:00PM EDT
    |After Hours : 7.98 0.00 (0.00%) Jul 31, 4:43PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Net Income (111,518) (46,732) (22,721)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation306  54  35  
    Adjustments To Net Income27,657  5,953  (472)
    Changes In Accounts Receivables(882) -  7  
    Changes In Liabilities14,078  7,291  (1,727)
    Changes In Inventories(7,771) -   -  
    Changes In Other Operating Activities(2,871)(885)115  
    Total Cash Flow From Operating Activities (81,001) (34,319) (24,763)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(1,489)(346)(24)
    Investments(11,508) -  4,212  
    Other Cash flows from Investing Activities -   -   -  
    Total Cash Flows From Investing Activities (12,997) (346) 4,188  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock112,586  75,684   -  
    Net Borrowings -   -   -  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 112,586   75,684   -  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 18,588   41,019   (20,575)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.